WEST PHARMACEUTICAL SERVICES, INC. Liability, Defined Benefit Plan, Noncurrent
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Liability, Defined Benefit Plan, Noncurrent of $28.30 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent · last filed 2026-07-23
- 2026-06-30: Liability, Defined Benefit Plan, Noncurrent $28.30M.
- 2026-03-31: Liability, Defined Benefit Plan, Noncurrent $28.50M.
- 2025-12-31: Liability, Defined Benefit Plan, Noncurrent $29.00M.
- 2025-09-30: Liability, Defined Benefit Plan, Noncurrent $31.10M.
| Period end | Liability, Defined Benefit Plan, Noncurrent |
|---|---|
| 2026-06-30 | $28.30M 10-Q · filed 2026-07-23 |
| 2026-03-31 | $28.50M 10-Q · filed 2026-04-23 |
| 2025-12-31 | $29.00M 10-Q · filed 2026-07-23 |
| 2025-09-30 | $31.10M 10-Q · filed 2025-10-23 |
| 2025-06-30 | $30.80M 10-Q · filed 2025-07-24 |
| 2025-03-31 | $28.60M 10-Q · filed 2025-04-24 |
| 2024-12-31 | $28.20M 10-K · filed 2026-02-17 |
| 2024-09-30 | $30.20M 10-Q · filed 2024-10-24 |
| 2024-06-30 | $29.10M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $28.90M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $29.60M 10-K · filed 2025-02-18 |
| 2023-09-30 | $28.40M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $27.30M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $27.20M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $28.20M 10-K · filed 2024-02-20 |
| 2022-09-30 | $35.20M 10-Q · filed 2022-10-27 |
| 2022-06-30 | $36.80M 10-Q · filed 2022-07-28 |
| 2022-03-31 | $38.70M 10-Q · filed 2022-04-28 |
| 2021-12-31 | $40.50M 10-K · filed 2023-02-21 |
| 2021-09-30 | $52.10M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $54.00M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $55.20M 10-Q · filed 2021-04-30 |
| 2020-12-31 | $57.50M 10-K · filed 2022-02-22 |
| 2020-09-30 | $51.60M 10-Q · filed 2020-10-23 |
| 2020-06-30 | $52.60M 10-Q · filed 2020-07-24 |
| 2020-03-31 | $50.70M 10-Q · filed 2020-04-24 |
| 2019-12-31 | $52.50M 10-K · filed 2021-02-23 |
| 2019-09-30 | $46.80M 10-Q · filed 2019-10-29 |
| 2019-06-30 | $53.60M 10-Q · filed 2019-07-29 |
| 2019-03-31 | $54.30M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $56.20M 10-K · filed 2020-02-24 |
| 2018-09-30 | $53.80M 10-Q · filed 2018-10-30 |
| 2018-06-30 | $53.60M 10-Q · filed 2018-07-31 |
| 2018-03-31 | $55.00M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $53.40M 10-K · filed 2019-02-28 |
| 2017-09-30 | $62.00M 10-Q · filed 2017-10-31 |
| 2017-06-30 | $60.10M 10-Q · filed 2017-08-01 |
| 2017-03-31 | $57.10M 10-Q · filed 2017-05-05 |
| 2016-12-31 | $75.60M 10-K · filed 2018-02-26 |
| 2016-09-30 | $62.50M 10-Q · filed 2016-10-31 |
| 2016-06-30 | $61.20M 10-Q · filed 2016-08-01 |
| 2016-03-31 | $60.50M 10-Q · filed 2016-05-06 |
| 2015-12-31 | $62.00M 10-K · filed 2017-02-28 |
| 2015-09-30 | $81.50M 10-Q · filed 2015-11-02 |
| 2015-06-30 | $63.00M 10-Q · filed 2015-08-03 |
| 2015-03-31 | $61.40M 10-Q · filed 2015-05-06 |
| 2014-12-31 | $83.70M 10-K · filed 2016-02-26 |
| 2014-09-30 | $75.00M 10-Q · filed 2014-11-03 |
| 2014-06-30 | $79.10M 10-Q · filed 2014-08-01 |
| 2014-03-31 | $82.80M 10-Q · filed 2014-05-08 |
| 2013-12-31 | $83.10M 10-K · filed 2015-02-25 |
| 2013-09-30 | $126.10M 10-Q · filed 2013-11-04 |
| 2013-06-30 | $138.00M 10-Q · filed 2013-08-05 |
| 2013-03-31 | $135.80M 10-Q · filed 2013-05-06 |
| 2012-12-31 | $135.40M 10-K · filed 2014-02-27 |
| 2012-09-30 | $114.80M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $112.30M 10-Q · filed 2012-08-06 |
| 2012-03-31 | $111.30M 10-Q · filed 2012-05-04 |
| 2011-12-31 | $126.00M 10-K · filed 2013-02-27 |
| 2011-09-30 | $84.10M 10-Q · filed 2011-11-07 |
| 2011-06-30 | $92.00M 10-Q/A · filed 2011-08-08 |
| 2011-03-31 | $91.20M 10-Q · filed 2011-05-05 |
| 2010-12-31 | $87.20M 10-K/A · filed 2012-03-01 |
| 2010-09-30 | $83.10M 10-Q · filed 2010-11-05 |
| 2010-06-30 | $79.30M 10-Q · filed 2010-08-05 |
| 2009-12-31 | $85.10M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |